Jun Liang

age ~63

from Denver, CO

Get Report

Also known as:

Jun Lang
Jun Lian

Connected to:

Jun Liang Phones & Addresses

Denver, CO
29960 Rancho California Rd, Temecula, CA 92591 • 9516766876
45660 Jaguar Way, Temecula, CA 92592
Las Vegas, NV
San Diego, CA
Riverside, CA

Work

Company:

Hope fashion
Jun 2013
Position:

Production &design assistant

Education

School / High School:

Fashion Institute of Design & Merchandising
Apr 2013
Specialities:

A.A.

Medicine Doctors

Jun H. Liang

view source

Specialties:

Family Medicine

Work:

Fairview Physician AssociatesFairview Clinic Savage
5725 Loftus Dr, Savage, MN 55378
9522269500 (phone), 9522269501 (fax)

Education:

Medical School
Beijing Med Univ, Beijing City, Beijing, China
Graduated: 1991

Procedures:

Destruction of Benign/Premalignant Skin Lesions
Electrocardiogram (EKG or ECG)
Hearing Evaluation
Skin Tags Removal
Vaccine Administration

Conditions:

Acute Pharyngitis
Acute Sinusitis
Acute Upper Respiratory Tract Infections
Anxiety Phobic Disorders
Gastroesophageal Reflux Disease (GERD)

Languages:

Chinese
English

Description:

Dr. Liang graduated from the Beijing Med Univ, Beijing City, Beijing, China in 1991. She works in Savage, MN and specializes in Family Medicine. Dr. Liang is affiliated with Fairview Southdale Hospital.

Name / Title

Company / Classification

Phones & Addresses

Jun Liang

Choice & Luxe Ltd. Liabiilty Co
Retail

848 N Rainbow Blvd, Las Vegas, NV 89107

Resumes

Jun Xiao Liang

view source

Location:

6458 Flanders Dr, Newark, CA 94560

Industry:

Apparel & Fashion

Languages:

Mandarin

Jun Jie David Liang

view source

Jun Liang

view source

Table Games Dealer

view source

Location:

Temecula, CA

Industry:

Food Production

Work:

Las Vegas Ventanas
Table Games Dealer

Jun Liang

view source

Jun Liang

view source

Jun Liang

view source

Jun Liang

view source

Location:

United States

Amazon

Party time difference(Chinese Edition)

view source

The book tells the life experiences and interesting stories of Chinese overseas students in foreign countries. Not as people's expectation, all of these overseas students do not live a superior life in the advanced capitalist countries, where they travel a lot and make friends during their stay ther...

Author
CENG LIANG JUN ZHU

Binding
Paperback

Pages
258

Publisher
Beijing Joint Publishing Company

ISBN #
7550221111

EAN Code
9787550221116

ISBN #
11

Yue Gui liang jun da zhan shi (Chinese Edition)

view source

Author
Peisheng. Li

Binding
Paperback

Pages
128

Publisher
University of Michigan Library

ISBN #
10

Interesting Astronomy (Chinese Edition)

view source

Author
zhao jun liang

Binding
Paperback

Pages
299

Publisher
Shanghai Lexicographical Publishing House

ISBN #
7532632954

EAN Code
9787532632954

ISBN #
8

Come to Wang Xizhi-Liang Xiaojun Interpreting Works of Wang Xizhi (Chinese Edition)

view source

Author
liang xiao jun

Binding
Paperback

Pages
199

Publisher
Guangxi Fine Arts Publishing House

ISBN #
7549403821

EAN Code
9787549403820

ISBN #
6

Legend of 20 Elites in Ancient and Modern Physics - Brilliant Starlight (Chinese Edition)

view source

Author
liang jun

Binding
Paperback

Pages
299

Publisher
Hubei Education Press

ISBN #
7535170919

EAN Code
9787535170910

ISBN #
4

Low Molecular Weight Protamine Peptides as Gene Delivery Carrier: A novel gene delivery agent

view source

Non viral gene delivery systems such as cationic lipids, synthetic polymers and peptides demonstrate significant advantages over the viral delivery systems that are usually associated with immunological responses and safety risks. Protamine, is a cationic peptide, used as a gene delivery carrier and...

Author
Riddhi Kharidia, Jun F. Liang

Binding
Paperback

Pages
64

Publisher
LAP LAMBERT Academic Publishing

ISBN #
3838378407

EAN Code
9783838378404

ISBN #
17

Expression of Garment Design in Garment Industry (Chinese Edition)

view source

This book mainly describes the drawing techniques and expression methods in the garment design procedure of garment industry combined with the practical need of industry, including five parts, i.e., general introduction to expression of garment design, body drawing of garment, expressions of flat ga...

Author
liu xing bang, wang xiao lei, liang jun

Binding
Paperback

Pages
199

Publisher
China Textile Press and Apparel Press

ISBN #
750644822X

EAN Code
9787040240368

ISBN #
15

HVDC Grids: For Offshore and Supergrid of the Future (IEEE Press Series on Power Engineering)

view source

Presents the advantages, challenges, and technologies of High Voltage Direct Current (HVDC) Grids Presents the technology of the future offshore and HVDC grid Explains how offshore and HVDC grids can be integrated in the existing power system Provides the required models to analyse the different ti...

Author
Dirk Van Hertem, Oriol Gomis-Bellmunt, Jun Liang

Binding
Hardcover

Pages
528

Publisher
Wiley-IEEE Press

ISBN #
1118859154

EAN Code
9781118859155

ISBN #
12

License Records

Jun Xiao Liang

Address:

6265 E Evans Ave #7, Denver, CO 80222

License #:

8047 - Expired

Issued Date:

Jul 1, 2009

Renew Date:

Feb 1, 2013

Expiration Date:

Jan 31, 2015

Type:

Massage Therapist

Us Patents

Inhibitors Of Akt Activity
view source
US Patent:

7910561, Mar 22, 2011
Filed:

Dec 9, 2005
Appl. No.:

11/792121
Inventors:

Jeannie M. Arruda - San Diego CA, US
Brian T. Campbell - San Diego CA, US
Nicholas D. P. Cosford - San Diego CA, US
Jacob M. Hoffman - Lansdale PA, US
Essa H. Hu - Camarillo CA, US
Mark E. Layton - Harleysville PA, US
Yiwei Li - Ambler PA, US
Jun Liang - Palo Alto CA, US
Kevin J. Rodzinak - Schwenksville PA, US
Tony Siu - Brookline MA, US
Brian A. Stearns - San Diego CA, US
Lida R. Tehrani - San Diego CA, US
Mark T. Bilodeau - Lansdale PA, US
Peter J. Manley - Harleysville PA, US
Assignee:

Merck Sharp & Dohme Corp. - Rahway NJ
International Classification:

A01N 43/04
A01N 43/58
A01N 43/42
A61K 31/541
A61K 31/70
A61K 31/50
A61K 31/495
A61K 31/52
C09B 25/00
C07D 487/00
C07D 491/00
C07H 15/00
US Classification:

514 43, 51421021, 514249, 51426322, 514314, 536 292, 544277, 544350, 546173
Abstract:

The present invention is directed to compounds which contain substituted naphthyridines which inhibit the activity of Akt, a serine/threonine protein kinase. The invention is further directed to chemotherapeutic compositions containing the compounds of this invention and methods for treating cancer comprising administration of the compounds of the invention. These substituted naphthyridines have unexpected advantageous properties when compared to other naphthyridines reported in PCT publication WO2003/086394, such unexpected advantageous properties may include increased cellular potency/solubility, greater selectivity, enhanced pharmacokinetic properties, lack of off target activity and so on.

Pyrimidyl Cyclopentanes As Akt Protein Kinase Inhibitors
view source
US Patent:

8003651, Aug 23, 2011
Filed:

Jul 5, 2007
Appl. No.:

11/773946
Inventors:

Ian S. Mitchell - Lafayette CO, US
James F. Blake - Longmont CO, US
Rui Xu - Longmont CO, US
Nicholas C. Kallan - Boulder CO, US
Dengming Xiao - Longmont CO, US
Keith Lee Spencer - Lyons CO, US
Josef R. Bencsik - Longmont CO, US
Eli M. Wallace - Lyons CO, US
Stephen T. Schlachter - Boulder CO, US
Anna L. Banka - Longmont CO, US
Jun Liang - Palo Alto CA, US
Brian Safina - Redwood City CA, US
Jun Li - Foster City CA, US
Christine Chabot - San Mateo CA, US
Assignee:

Array BioPharma Inc. - Boulder CO
Genertech, Inc. - South San Francisco CA
International Classification:

C07D 239/70
A61K 31/497
A61P 35/00
A61P 29/00
A61P 25/28
A61P 9/00
US Classification:

51425216, 544253
Abstract:

The present invention provides compounds of Formula I, including tautomers, resolved enantiomers, diastereomers, solvates, metabolites, salts and pharmaceutically acceptable prodrugs thereof.

Hydroxylated And Methoxylated Pyrimidyl Cyclopentanes As Akt Protein Kinase Inhibitors
view source
US Patent:

8063050, Nov 22, 2011
Filed:

Jul 5, 2007
Appl. No.:

11/773949
Inventors:

Ian S. Mitchell - Lafayette CO, US
James F. Blake - Longmont CO, US
Rui Xu - Longmont CO, US
Nicholas C. Kallan - Boulder CO, US
Dengming Xiao - Longmont CO, US
Keith Lee Spencer - Lyons CO, US
Josef R. Bencsik - Longmont CO, US
Eli M. Wallace - Lyons CO, US
Stephen T. Schlachter - Boulder CO, US
Anna L. Banka - Longmont CO, US
Jun Liang - Palo Alto CA, US
Brian Safina - Redwood City CA, US
Birong Zhang - Union City CA, US
Christine Chabot - San Mateo CA, US
Steven Do - San Jose CA, US
Assignee:

Array BioPharma Inc. - Boulder CO
Covenentech, Inc. - South San Francisco CA
International Classification:

C07D 239/70
A61K 31/496
A61P 35/00
US Classification:

51425216, 544253
Abstract:

The present invention provides compounds, including resolved enantiomers, resolved diastereomers, solvates and pharmaceutically acceptable salts thereof, comprising the Formula I:Also provided are methods of using the compounds of this invention as AKT protein kinase inhibitors and for the treatment of hyperproliferative diseases such as cancer.

5H-Cyclopenta[D]Pyrimidines As Akt Protein Kinase Inhibitors
view source
US Patent:

8329709, Dec 11, 2012
Filed:

Jan 9, 2009
Appl. No.:

12/812377
Inventors:

Anna L. Banka - Boulder CO, US
Josef R. Bencsik - Boulder CO, US
James Blake - Boulder CO, US
Martin Hentemann - Boulder CO, US
Nicholas C. Kallan - Boulder CO, US
Jun Liang - South San Francisco CA, US
Ian S. Mitchell - Boulder CO, US
Stephen T. Schlachter - Boulder CO, US
Eli M. Wallace - Boulder CO, US
Rui Xu - Boulder CO, US
Tony P. Tang - Boulder CO, US
Assignee:

Genentech, Inc. - South San Francisco CA
Array BioPharma Inc. - Boulder CO
International Classification:

A61K 31/517
C07D 239/70
US Classification:

5142581, 544253
Abstract:

Compounds of Formula I are useful for inhibiting AKT protein kinases. Methods using compounds of Formula I and stereoisomers and pharmaceutically acceptable salts thereof, for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such disorders in mammalian cells, or associated pathological conditions are disclosed. Formula (I).

Pyrimidyl Cyclopentanes As Akt Protein Kinase Inhibitors
view source
US Patent:

8377937, Feb 19, 2013
Filed:

Jul 3, 2008
Appl. No.:

12/667850
Inventors:

Josef R. Bencsik - Longmont CO, US
James F. Blake - Longmont CO, US
Nicholas C. Kallan - Boulder CO, US
Ian S. Mitchell - Lafayette CO, US
Keith L. Spencer - Lyons CO, US
Dengming Xiao - Longmont CO, US
Rui Xu - Longmont CO, US
Christine Chabot - Menlo Park CA, US
Jun Liang - Palo Alto CA, US
Brian S. Safina - Redwood City CA, US
Assignee:

Array BioPharma Inc. - Boulder CO
Genentech, Inc. - South San Francisco CA
International Classification:

C07D 239/70
A61K 31/517
US Classification:

51425216, 544253
Abstract:

The present invention provides compounds of Formula I, including tautomers, resolved enantiomers, diastereomers, solvates, metabolites, salts and pharmaceutically acceptable prodrugs thereof. Also provided are methods of using the compounds of this invention as AKT protein kinase inhibitors and for the treatment of hyperproliferative diseases such as cancer.

Pyrimidyl Cyclopentanes As Akt Protein Kinase Inhibitors
view source
US Patent:

8618097, Dec 31, 2013
Filed:

Jul 3, 2008
Appl. No.:

12/667848
Inventors:

Josef Bencsik - Longmont CO, US
James F. Blake - Longmont CO, US
James M. Graham - Longmont CO, US
Martin F. Hentemann - Lafayette CO, US
Nicholas C. Kallan - Boulder CO, US
Ian S. Mitchell - Lafayette CO, US
Stephen T. Schlachter - Boulder CO, US
Keith L. Spencer - Lyons CO, US
Dengming Xiao - Longmont CO, US
Rui Xu - Longmont CO, US
Mike Welch - Westminster CO, US
Jun Liang - Palo Alto CA, US
Brian S. Safina - Redwood City CA, US
Assignee:

Array Biopharma, Inc. - Boulder CO
Genentech, Inc. - South San Francisco CA
International Classification:

A61K 31/5377
A61K 31/496
C07D 413/14
C07D 239/70
A61P 25/28
A61P 35/00
A61P 29/00
A61P 9/00
US Classification:

5142345, 51425215, 51425216, 544121, 544230, 544253
Abstract:

The present invention provides compounds of Formula (I), including tautomers, resolved enantiomers, diastereomers, solvates, metabolites, salts and pharmaceutically acceptable prodrugs thereof. Also provided are methods of using the compounds of this invention as AKT protein kinase inhibitors and for the treatment of hyperproliferative diseases such as cancer.

Hydroxylated Pyrimidyl Cyclopentane As Akt Protein Kinase Inhibitor
view source
US Patent:

20100292244, Nov 18, 2010
Filed:

Jan 9, 2009
Appl. No.:

12/811983
Inventors:

Josef Bencsik - Boulder CO, US
James F. Blake - Boulder CO, US
Nicholas C. Kallan - Boulder CO, US
Ian S. Mtchell - Boulder CO, US
Keith L. Spencer - Boulder CO, US
Dengming Xiao - Boulder CO, US
Rui Xu - Boulder CO, US
Christine Chabot - South San Francisco CA, US
Steven Do - South San Francisco CA, US
Jun Liang - South San Francisco CA, US
Brian Safina - South San Francisco CA, US
Birong Zhang - South San Francisco CA, US
Assignee:

Array BioPharma Inc. - Boulder CO
International Classification:

A61K 31/517
C07D 403/04
A61P 29/00
A61P 35/00
A61P 9/00
A61P 25/00
A61P 17/00
A61P 15/02
US Classification:

51425216, 544253
Abstract:

The present invention provides a compound and pharmaceutically acceptable salts thereof, comprising the Formula I. Also provided are methods of using the compound of this invention as an AKT protein kinase inhibitor and for the treatment of hyperproliferative diseases such as cancer.

Hydroxylated Pyrimidyl Cyclopentanes As Akt Protein Kinase Inhibitors
view source
US Patent:

20110065716, Mar 17, 2011
Filed:

Jan 9, 2009
Appl. No.:

12/811957
Inventors:

Josef R. Bencsik - Boulder CO, US
James F. Blake - Boulder CO, US
Nicholas C. Kallan - Boulder CO, US
Ian S. Mitchell - Boulder CO, US
Keith Lee Spencer - Boulder CO, US
Dengming Xiao - Boulder CO, US
Rui Xu - Boulder CO, US
Christine Chabot - South San Francisco CA, US
Steven Do - South San Francisco CA, US
Jun Liang - South San Francisco CA, US
Brian Safina - South San Francisco CA, US
Birong Zhang - South San Francisco CA, US
Assignee:

Array BioPharma Inc. - Boulder CO
International Classification:

A61K 31/517
C07D 403/04
A61P 35/00
A61P 25/28
A61P 9/00
A61P 29/00
A61P 15/00
A61P 17/00
US Classification:

51425216, 544253
Abstract:

The present invention provides compounds, including pharmaceutically acceptable salts thereof, comprising the Formula (I): Also provided are methods of using the compounds of this invention as AKT protein kinase inhibitors and for the treatment of hyperproliferative diseases, such as cancer.

News

Samsung will mass produce Qualcomm's Snapdragon 820 chips

view source

Letv has already established itself as one of the worlds top innovators and our decision to include the Snapdragon 820 processor in these new devices demonstrates our commitment to creating and delivering the best technology available to our customers, Jun Liang, chief operating officer at Letv sa
Date: Jan 14, 2016
Category: Sci/Tech
Source: Google

'Evil spirit' scam plagues Asian immigrants in NYC

view source

Manhattan prosecutors charged the five with grand larceny. They are all from China. Lawyers for three didn't return calls seeking comment. But a lawyer for Jun Liang, 44, and Jingchang Quan, 44 said his clients were innocent.
Date: Jul 05, 2013
Source: Google